<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101311472</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34100</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Stem Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Stem Cell</journal-id>
<journal-title-group>
<journal-title>Cell stem cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1934-5909</issn>
<issn pub-type="epub">1875-9777</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31155484</article-id>
<article-id pub-id-type="pmc">6609489</article-id>
<article-id pub-id-type="doi">10.1016/j.stem.2019.04.021</article-id>
<article-id pub-id-type="manuscript">NIHMS1528543</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chanda</surname>
<given-names>Soham</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
<xref ref-type="author-notes" rid="FN3">‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ang</surname>
<given-names>Cheen Euong</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Qian Yi</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghebrial</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haag</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shibuya</surname>
<given-names>Yohei</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wernig</surname>
<given-names>Marius</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Südhof</surname>
<given-names>Thomas C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Cellular Physiology, and Howard Hughes Medical Institute; Stanford University School of Medicine, Stanford, CA 94305, USA</aff>
<aff id="A2"><label>2</label>Institute for Stem Cell Biology and Regenerative Medicine, and Department of Pathology; Stanford University School of Medicine, Stanford, CA 94305, USA</aff>
<aff id="A3"><label>3</label>Department of Bioengineering; Stanford University School of Medicine, Stanford, CA 94305, USA</aff>
<aff id="A4"><label>4</label>Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA;</aff>
<aff id="A5"><label>5</label>Singapore Bioimaging Consortium, Agency for Science, Technology and Research, Singapore 138667;</aff>
<aff id="A6"><label>6</label>Hopp Children’s Cancer Center (KiTZ), Heidelberg 69120, Germany</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">S.C. conceived the project and supervised the experiments; S.C. and T.C.S. designed the experiments; S.C., C.E.A., Q.Y.L., M.G., D.H. and Y.S. conducted the experiments and analyzed the data; S.C. and T.C.S. wrote the paper; all authors reviewed the manuscript.</p>
</fn>
<fn fn-type="other" id="FN3">
<label>‡</label>
<p id="P3">Lead contact: SC</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence should be addressed to: SC (<email>soham.chanda@colostate.edu</email>); TCS (<email>tcs1@stanford.edu</email>)</corresp>
<fn fn-type="COI-statement" id="FN5">
<p id="P67">DECLARATION OF INTERESTS</p>
<p id="P68">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>03</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>25</volume>
<issue>1</issue>
<fpage>103</fpage>
<lpage>119.e6</lpage>
<!--elocation-id from pubmed: 10.1016/j.stem.2019.04.021-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P4">Human pluripotent stem cells can be rapidly converted into functional neurons by ectopic expression of proneural transcription factors. Here we show that directly reprogrammed neurons, despite their rapid maturation kinetics, can model teratogenic mechanisms that specifically affect early neurodevelopment. We delineated distinct phases of <italic>in vitro</italic> maturation during reprogramming of human neurons and assessed the cellular phenotypes of Valproic acid (VPA), a teratogenic drug. VPA exposure caused chronic impairments in dendritic morphology and functional properties of developing neurons, but not those of mature neurons. These pathogenic effects were associated with VPA-mediated inhibition of histone deacetylase (HDAC) and glycogen synthase kinase-3 (GSK-3) pathways, which caused transcriptional down-regulation of many genes including MARCKSL1, an actin-stabilizing protein essential for dendritic morphogenesis and synapse maturation during early neurodevelopment. Our findings identify a developmentally restricted pathogenic mechanism of VPA and establish the use of reprogrammed neurons as an effective platform for modeling teratogenic pathways.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract</title>
<p id="P5">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1528543-f0001.jpg"></graphic>
</p>
</abstract>
<abstract abstract-type="summary" id="ABS3">
<title>eTOC BLURB</title>
<p id="P6">Chanda, Südhof, and colleagues used reprogrammed human neurons to model the neurodevelopmental toxicity induced by prenatal exposure to Valproic acid, a potent teratogenic compound. By analyzing different phases of neuronal maturation <italic>in vitro</italic>, the authors identified Valproate-mediated cellular mechanisms that selectively impair the neuronal properties at early developmental stages.</p>
</abstract>
<kwd-group>
<kwd>Cellular reprogramming</kwd>
<kwd>Human neurons</kwd>
<kwd>Neurodevelopment</kwd>
<kwd>Valproic acid</kwd>
<kwd>Anti-epileptic drug</kwd>
<kwd>Spina Bifida</kwd>
<kwd>Autism</kwd>
<kwd>Gene expression</kwd>
<kwd>MARCKSL1</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>